Institute of Cancer Research / Rutgers Cancer Institute of New Jersey / University of Chicago / AR complex / The terminal / /
IndustryTerm
treatment of prostate cancer / Cancer Therapy / treatment of two LuCap prostate cancer / treatment of castration‑resistant prostate cancer / prostate cancer treatment / energy / food effect / prostate cancer care / food effect resulting / therapy for treatment of metastatic prostate cancer / /
MedicalCondition
metastatic prostate cancer / prostate cancers / nausea / hyperaldosteronism / treatment INTRODUCTION Prostate cancer / fatigue / fatal cardiovascular disease / diarrhea / frequently diagnosed cancer / visceral metastatic disease / prostate cancer / constipation / pruritus / pneumonitis / dissociation / tumor / congenital adrenal hyperplasia leading / advanced prostate cancer / hypertension / cancer / tumors / disease / castration‑resistant prostate cancer / dyspnea / hyperglycemia / dyslipidemia / stroke / bone metastases / bone metastasis / pain / xenograft prostate cancer / potential characteristics driving tumor / tumor cells / controlled hypertension / LuCap prostate cancer / refractory prostate cancer / Deficiency / hypokalemia / painful bone metastases / metastatic castration‑resistant prostate cancer / prostate cancer LAPC4 / monitoring for hypertension / /
Rutgers / Food and Drug Administration / Independent Data Monitoring Committee / Rutgers Cancer Institute of New Jersey / Institute of Cancer Research in London / the University of Chicago / US Federal Reserve / Department of Surgery / /
Asian Journal of Andrology[removed], 387–400 © 2014 AJA, SIMM & SJTU. All rights reserved 1008-682X www.asiaandro.com; www.ajandrology.com